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1. Introduction 
The amino acid L-dihydroxyphenylalanine 
(L-DOPA), the immediate precursor of dopamine, is 
administered in doses of up to several grams per day 
to patients suffering from Parkinson’s disease [l-3]. 
Such high amounts are required to at least partially 
compensate [4] for the dopamine deficiency in certain 
regions of the brain of such patients [5-81. The ques- 
tion arises whether L-DOPA, which is apparently only 
a transient intermediate in the biosynthesis of catechol- 
amines and melanin, might also be incorporated into 
proteins under conditions of vast excess of L-DOPA. 
This possibility can be tested by assaying whether 
L-DOPA can be bound enzymatically to one or several 
species of transfer RNA. That this may indeed occur 
has been made likely by the results [9] demonstrat- 
ing that tyrosyl tRNA synthetase from E. coli will 
catalyze the pyrophosphate-ATP exchange reaction 
not only in the presence of L-tyrosine but also with 
L-DOPA. In this communication we report the binding 
of L-DOPA to E. coli tRNA. However, similar experi- 
ments with the respective components from mouse 
cells gave no indication for the enzymatic activation 
of L-DOPA. 
2. Materials and methods 
2.1. Materials 
E. coli tRNA was obtained from Schwarz/Mann 
Co. (Orangeburg, NY). Mouse liver tRNA was prepared 
as in [lo] with the following modifications: total 
RNA was not extracted with 1 M NaCl but instead 
Elsevier/North-Holland Biomedical Press 
dissolved in equilibration buffer and directly applied 
to the DEAE-cellulose column. For the elution of 
tRNA from the column the concentration of NaCl 
was increased to 1 M. Ascites tRNA was a gift of Dr 
R. Nolan (Sandoz Forschungsinstitut, Vienna). 
L-[3H]DOPA was purchased from The Radiochemi- 
cal Centre (Amersham). Specific activities of different 
samples ranged from 1.7-2.5 mCi/mmol. Labelled 
DOPA obtained after Jan. 1977 gave high blanks due 
to unspecific binding to tRNA of some unknown 
contaminant. This could partly be overcome by first 
treating the radioactive amino acid with ascorbate. 
For the experiments with mouse liver tRNA, 1 part 
[3H]DOPA solution was mixed with 1 part 0.5 M 
ascorbate for 15 min at room temperature. Immedi- 
ately before use, this mixture was adjusted to pH 6 
with 0.1 N NaOH. 
2.2. Cell extracts 
For the determination of tRNA-amino acid accep- 
tor activities crude enzyme preparations were used, 
derived either from E. coli D-10 or from mouse cells. 
In case of the E. coli extract the supernatant obtained 
after centrifugation at 100 000 X g(S-100) was passed 
over a DEAE-cellulose column to remove endogenous 
tRNA [ 111. The mouse liver extract was prepared as 
in [ 121; in one preparation the protamine sulfate and 
ammonium sulfate steps were omitted. The enzyme 
preparations were extensively dialyzed to remove 
trace amounts of unlabelled amino acids. 
2.3. Estimation of amino acid acceptor activities 
The assays were carried out in 100 ~1 incubation 
mixtures which were 40 mM in Hepes, pH 8,25 mM 
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in KCI, 5 mM in MgCla, 1 mM in ATP, 25 PM in CTP, 
1 mM in EDTA, 10 mM in dithioerythritol and con- 
tained 0.032 mg E. coli S-100 extract protein or 
O-14-0.26 mg mouse liver S-100 extract protein, 
0.0354.4 A2e0 units tRNA, 10 &i [3H]DOPA or 
[3H]tyrosine and, in some experiments, nonradioactive 
amino acids in quantities as indicated in tables 1 and 
2. The mixtures were incubated for 15 min at 37°C 
and the reactions terminated by the addition of 3 ml 
of ice cold 10% trichloroacetic acid. The precipitated 
tRNAs were filtered under suction through Whatman 
GF/C filter discs. The filters were washed subsequently 
five times each with 5% trichloroacetic acid and finally 
twice with ethanol. The filters were then dried and 
counted in a toluene based scintillation fluid. 
2.4. Separation of tRNA by column chromatography 
For the separation of the tRNA mixture the RPC 5 
technique [ 131 was followed. The plaskon-like material 
Voltalef@ (Ugine Kuhlmann, Rhone) was employed 
as a solid support. The size of the column was 
0.5 X 110 cm and it was operated under pressure at 
37°C. 100 Aw units tRNA were applied and eluted 
with 2 X 200 ml NaCl gradient ranging from 0.5-0.9 M 
Fractions, 4 ml, were collected. The tyrosine acceptor 
tests of the various fractions were as in [ 141. 
2.5. Identification of DOPA bound to tRNA 
After counting, the Whatman GF/C discs were 
washed free of scintillation chemicals. Subsequently, 
they were treated at 95’C for 90 min in 1 N HCl in 
the presence of 10 vg unlabelled DOPA. The solution 
was then filtered, dried and applied to Whatman 3 MM 
paper. DOPA was identified by descending paper 
chromatography (butanol:acetic acid:water = 4: 1:2) 
and/or by paper electrophoresis at pH 1.8 (10% acetic 
acid adjusted with formic acid, 40 V/cm, 120 min), 
using authentic DOPA as marker. 
3. Results and conclusions 
In a first series of experiments the possibility that 
L-DOPA will be accepted by tRNA was assayed using 
both a crude enzyme and tRNA from E. coli. As 
shown in table 1, a significant amount of radioactive 
DOPA is bound to tRNA. To exclude a possible bind- 
ing of a contaminant present in the radioactive DOPA, 
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Table 1 




pmoles [ 3H]- 
DOPA bound 
1 [ 3H]DOPA 13.2 
[3H]DOPA, 10 pmoles tyrosine 9.9 
[ 3H]DOPA, 50 pmoles tyrosine 2.8 
[‘HIDOPA, 1 nmole tyrosine 0 
2 [ ‘H]DOPA 15.5 
[ ‘H]DOPA, 19 amino acids 16.2 
3 [ 3H]DOPA 6 
[ 3H ]DOPA, tyrosine 0 
Experiments 1 and 2: 0.3 A,,, units of E. coli B tRNA was 
incubated as described in the experi~mental section in the 
presence of 4.8 nmoles (expt. 1) and 4.2 nmoles (expt. 2) 
L-[ 3H]DOPA with and without the addition of nonradioactive 
amino acids. In experiment 1, L-tyrosine was added in amounts 
as indicated in the table. In experiment 2, a mixture of 19 
amino acids minus tyrosine, 20 pmoles each, was added. The 
(‘Hltyrosine acceptor activity of the tRNA, assayed under 
similar conditions, was 17.2 pmoles. 
Experiment 3: 0.035 A,,, units of an enriched tyrosine spe- 
cific tRNA, purified by RCPJ, was incubated in the presence 
of 5.9 nmoles L-[3H]DOPA with and without 0.5 nmoles of 
nonradioactive L-tyrosine. In all three experiments, a blank 
of 2-2.2 pmoles was substracted from each measurement 
samples were hydrolyzed in 1 N HCl and subsequently 
fractioned by paper electrophoresis and chromatog 
raphy. More than 80% total radioactivity present in 
the sample comigrated with authentic unlabelled 
DOPA. 
Binding of labelled DOPA to tRNA was strongly 
inhibited in the presence of unlabelled L-tyrosine 
(exp. 1, table 1). The affinity for tyrosine must be at 
least two orders of magnitude higher than for L-DOPA. 
It appears that only L-tyrosine, but none of the other 
19 amino acids, can suppress the activation of DOPA. 
In line with this is the observation that DOPA also 
binds to a fraction of tRNA enriched for tRNAn” by 
RPC-5 chromatography and that this binding is again 
inhibited by L-tyrosine (exp. 3, table 1). 
Similar experiments were performed with an 
extract from mouse liver and tRNA from the same 
source or from Krebs II mouse ascites cells. As shown 
in table 2, variable binding of radioactivity to tRNA 
was observed. However, this binding could not be 
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Table 2 
Binding of radioactive DOPA to mouse tRNA 
Exp. Additions [sH]-DOPA 
no. bound (pmol) 
1 [ ‘H]DOPA 8.17 
[ ‘H]DOPA, tyrosine 8.29 
[ ‘H]DOPA, no tRNA 5.30 
2 [ ‘HH]DOPA 6.60 
[ 3H]DOPA, no enzyme 8.70 
__~-- 
Exp. 1: Ascites tRNA (4.3 A,,, units) was incubated in the 
presence of mouse liver extract and 4.8 nmol L-[3H]DOPA 
with and without 1 nmol nonradioactive tyrosine. 
Exp. 2: Mouse liver tRNA (3.6 A,,, units) was incubated 
with radioactive DOPA (3.4 nmol) as above, in this case with 
a mouse liver extract from which endogenous tRNAs had 
been removed by treatment with protamine sulfate. For this 
experiment, the [ ‘H]DOPA has been pretreated with ascorbate 
(see section 2). 
In a similar assay, the acceptor activity of ascites tRNA for 
[ ‘Hltyrosine was 32.3 pmol 
prevented by adding unlabelled tyrosine to the sam- 
ples or by incubating tRNA and [3H]DOPA in the 
absence of enzyme (mouse liver extract). Moreover, 
after cleavage of the bound radioactivity with 1 N 
HCl and subsequent fractionation by paper electro- 
phoresis at pH 1.8, less than 10% total label co-migrated 
with authentic DOPA, both in complete samples and 
in controls. We were thus observing unspecific, non- 
enzymatic binding of a contaminant, probably an 
oxidation product, present in the radioactive DOPA. 
This unspecific binding apparently increased with the 
age of the [3H]DOPA preparation and batches of 
radioactive amino acid purchased in 1977 gave dis- 
tinctly higher values than earlier ones. In all these 
experiments we could not obtain any evidence for the 
charging of L-DOPA to mouse tRNA with mouse liver 
activating enzymes. In exp. 2, table 2, the mouse liver 
extract had been freed of endogenous tRNA in order 
to avoid any possible contamination of the test system 
by tyrosine which could have been liberated from 
tyrosyl-tRNA. However, as the experiments of table 2 
show, neither of the S-100 extracts containing or 
lacking endogenous tRNA promoted binding of 
L-DOPA to liver or ascites tRNA. The mouse liver 
extract was also inactive in assays with tRNA from 
E. coli (data not shown). 
Our results demonstrate that L-DOPA can indeed 
be enzymatically bound to E. coli tRNAw’. It is note- 
worthy that the enzymatic binding of L-DOPA to 
tRNA was observed under the standard conditions 
used for assaying the acceptor activity of amino acids. 
Special additions, like ethanol etc. required to induce 
mischarging are not necessary for the binding of 
GDOPA in the homologous E. coli system. 
In the mouse system, enzymatic binding of DOPA 
to tRNA could not be demonstrated. Apparently this 
animal system has a more efficient way of discriminat- 
ing between L-tyrosine and L-DOPA. Since a similar 
situation can be expected to exist in human cells, the 
formation of DOPA-containing proteins, even in the 
presence of ‘unphysiologically’ large concentrations 
of L-DOPA as used in the treatment of Parkinson’s 
disease, is most unlikely. 
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